Ocata Therapeutics Inc fka OCAT

[2020]

If we see much larger sells by Rabin and other insiders then I may have to worry. 60K is nothing. If the Company went belly up Rabin and others would loose their share value too.
I can't see that happening. In the race to get their Stem Cells to market a number of Bio Companies are going to fall over. The huge money required to progress the science to a point where income starts to trickle in is staggering as is the time it takes.
At the end of the day there will have winners and losers. IMO ACTC will be a winner despite pending litigation and scarce funding.
My one concern is How is it that other Bio Companies with much the same product are catching up to ACTC when they all have to go through the same or similar red tape?. If the answer is because ACTC has been dragging their feet then someone need to pull their finger out.